About 470,000 blister packages of prescription medication are being recalled by Sandoz and Novartis.
The prescription drug packaging isn’t child-resistant as required by the Poison Prevention Packaging Act, posing a poisoning risk if swallowed by children.
The firms have received one report of a child ingesting haloperidol from a blister pack.
This recall involves blister packages of prescription drugs from Novartis and Sandoz. The drugs are packaged with three to 10 tablets per blister card.
The recalled Novartis prescription blister packages have “Novartis,” the name of the drug, dosage, NDC, lot number, and expiration date printed on the cartons and the blister cards. The recalled Sandoz prescription blister packages have “Sandoz,” the name of the drug, dosage, NDC, and lot number printed on the cartons and the blister cards.
For details on which prescription drugs are involved in the recall, click here.
Consumers should immediately secure the blister cards to keep them out of the sight and reach of children and contact Novartis or Sandoz for further instructions, the company and U.S. Consumer Product Safety Commission advise. Novartis and Sandoz say consumers should continue to use the medication as directed once the blister packages are secured.
For more information, call Sandoz and Novartis at 888-669-6682 from Monday to Friday, 8 a.m. to 8 p.m. ET and Saturday and Sunday, 9 a.m. to 6 p.m. ET, visit www.us.sandoz.com and click on “Patients and Customers” then “Product Safety Notices,” or go to www.pharma.us.novartis.com and click on the banner “Novartis recalls select product blister packs.”
